Neoadjuvant Chemotherapy With Cabazitaxel

• Status: Terminated
• Trial end date: 2016-01-01

Summary

This study is aimed at evaluating the efficacy regarding the response rate and metastasis-free survival time of cabazitaxel as a neoadjuvant treatment in patients with high risk prostate cancer.

• Phase: Phase 2

Details

• Lead Sponsor: RWTH Aachen University